Clinical trials: Any Solid Tumor
Solid Tumor, Cancer
MVX-ONCO-1 in Patients With Solid Tumor
The objectives are to assess the safety and tolerability of 6 vaccine doses of MVX-ONCO-1, administered sub-cutaneously (injections and capsules implantations), in patients with advanced metastatic solid tumor in progression who…
- Trial name
- NCT02193503
- Testing
- Treatment
- Where
- Switzerland
- Volunteers
- 34 people
- Sponsor
- Maxivax SA